|
WO2005085283A1
|
|
Modified interleukin-11 and medicinal composition containing the same
|
|
WO2005082865A1
|
|
Fused bicyclic pyrimidine derivative
|
|
WO2005077364A1
|
|
Transdermal solifenacin preparation and method of improving transdermal permeability thereof
|
|
WO2005074928A1
|
|
Remedy for hypertension
|
|
JP2005103319A
|
|
Water-insoluble porous particles of biocompatible substances and process for producing the same
|
|
WO2005051382A1
|
|
Agent enhancing lipid-loewring effect
|
|
ZA200409391B
|
|
Azulene derivatives and salts thereof
|
|
JP2005120102A
|
|
Fused heteroaryl derivative
|
|
US2005175689A1
|
|
Coated fine particles containing drug for intrabuccally fast disintegrating tablet
|
|
WO2005039542A1
|
|
Drug-containing coated microparticle for orally disintegrating tablet
|
|
JP2005112858A
|
|
Water-insoluble porous particle of biocompatible substance and process for producing the same
|
|
WO2005026117A1
|
|
Preventive for cerebral stroke recurrence
|
|
JP2005089451A
|
|
Amide derivative or salt thereof
|
|
JP2005089452A
|
|
Tetrahydro-2h-thiopyrane-4-carboxamide derivative
|
|
JP2005060378A
|
|
Freeze-dried preparation containing physiologically active protein
|
|
JP2005060377A
|
|
Freeze-dried preparation containing interleukin-11
|
|
JP2005053903A
|
|
Quinolone derivative or its salt
|
|
TW200600119A
|
|
Enteric sustained-release fine particles of tamsulosin or its salt and manufacturing method thereof
|
|
WO2005002590A1
|
|
Agent inducing increase in bone mass
|
|
EP1529526A1
|
|
Sustained-release pharmaceutical compositon
|
